Identification of a Golgi-localized UDP-N-acetylglucosamine transporter in 
                   by unknown
RESEARCH ARTICLE Open Access
Identification of a Golgi-localized UDP-N-
acetylglucosamine transporter in
Trypanosoma cruzi
Carlos Gustavo Baptista1†, Elizabeth Cristina Rodrigues2†, Patricia Morking3, Amanda Klinke3, Maria Luiza Zardo3,
Maurílio José Soares3, Alessandra Melo de Aguiar3, Samuel Goldenberg3 and Augusto Savio Peixoto Ramos3*
Abstract
Background: Nucleotide sugar transporters (NSTs) play an essential role in translocating nucleotide sugars into the
lumen of the endoplasmic reticulum and Golgi apparatus to be used as substrates in glycosylation reactions. This
intracellular transport is an essential step in the biosynthesis of glycoconjugates.
Results: We have identified a family of 11 putative NSTs in Trypanosoma cruzi, the etiological agent of Chagas’ disease.
A UDP-N-acetylglucosamine transporter, TcNST1, was identified by a yeast complementation approach. Based on a
phylogenetic analysis four candidate genes were selected and used for complementation assays in a Kluyveromyces
lactis mutant strain. The transporter is likely expressed in all stages of the parasite life cycle and during differentiation
of epimastigotes to infective metacyclics. Immunofluorescence analyses of a GFP-TcNST1 fusion protein indicate that
the transporter is localized to the Golgi apparatus. As many NSTs are multisubstrate transporters, we also tested the
capacity of TcNST1 to transport GDP-Man.
Conclusions: We have identified a UDP-N-acetylglucosamine transporter in T. cruzi, which is specifically localized to the
Golgi apparatus and seems to be expressed, at the mRNA level, throughout the parasite life cycle. Functional studies of
TcNST1 will be important to unravel the role of NSTs and specific glycoconjugates in T. cruzi survival and infectivity.
Keywords: Glycoconjugates, Nucleotide sugar, Transporter, Trypanosomatids
Background
Trypanosoma cruzi is the etiological agent of Chagas’
disease, which affects approximately 7 million people,
mostly in Latin America, but also in other regions due to
migration and blood transfusion [1]. The life cycle of this
parasite is complex, involving at least four well-defined life
forms: the proliferative forms present in both the insect
vector (epimastigotes) and mammals (intracellular amasti-
gotes) and the infectious non-dividing metacyclics (insect
stage) and bloodstream trypomastigotes [2].
The dense glycocalyx of T. cruzi plays a fundamental
role in survival and infectivity, and its molecular com-
position depends on the parasite’s life form. The glycoca-
lyx is rich in glycoinositolphospholipids (GIPLs), either
free or as protein-membrane anchors. Free GIPLs are
major cell surface constituents of the insect stages of the
parasite acting as modulators of the host immune
system [3] and in epimastigote attachment to the midgut
surface of the vector [4].
Mucins, the most abundant glycoproteins of T. cruzi, are
highly O-glycosylated proteins tethered to the membrane
via glycosylphosphatidylinositol (GPI) anchors. They are
involved in protection against intestinal proteases in the
insect vector [5] and with the attachment to and invasion
of mammalian cells [6]. In terms of structure, it is import-
ant to note that the O-linked glycans of T. cruzi mucins
are attached to serine (Ser) or threonine (Thr) residues by
N-acetylglucosamine instead of N-acetylgalactosamine as
it occurs in most mammalian mucins [7].
As in other eukaryotes, the synthesis of T. cruzi glyco-
conjugates occurs in the lumen of the endoplasmic
reticulum (ER) and Golgi apparatus through the action of
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glycosyltransferases using nucleotide sugars as substrates.
These sugar-activated donors must be transported across
the ER and Golgi membranes by nucleotide sugar trans-
porters (NSTs). This intracellular transport is essential for
proper protein and lipid glycosylation.
NSTs comprise a family of structurally related and
highly hydrophobic type III transmembrane proteins, which
have been studied in different organisms, from yeast to
human [8]. Based on a detailed membrane topology study
of the mouse CMP-sialic acid transporter [9], these trans-
porters are supposed to have 10 transmembrane (TM) do-
mains with both amino- and carboxyl-termini facing the
cytosol. Mutations in NSTs are associated with widespread
defects in glycosylation leading to developmental diseases
in mammals and loss or attenuated infectivity of human
pathogens [10].
In parasitic protozoa, the role of NSTs has been inves-
tigated in Leishmania spp. [11, 12], T. brucei [13] and
Toxoplasma gondi [14]. In L. major, knockout of the GDP-
mannose (GDP-Man) transporter LPG2 resulted in mu-
tants deficient in cell-surface phosphoglycan molecules dis-
playing attenuated virulence in mice [15]. Recently, four
NSTs from T. brucei (TbNST1-4) were characterized [13].
Silencing and knockout experiments of TbNST4, which
transports UDP-N-acetylglucosamine (UDP-GlcNAc), UDP-
N-acetylgalactosamine (UDP-GalNAc) and GDP-Man,
resulted in glycosylation defects, but no impairment
of infectivity was observed, likely due to redundancy
in function.
In this study, we have identified a UDP-GlcNAc trans-
porter from T. cruzi (named TcNST1) by yeast complemen-
tation in vivo. We show that TcNST1 is localized to the
Golgi apparatus and that the gene is likely expressed during
the parasite life cycle and in vitro metacyclogenesis—a
process by which epimastigote forms differentiate into
infective metacyclic trypomastigotes. This is the first
experimentally characterized NST in T. cruzi, for which
there is relatively little information regarding glycocon-
jugate biosynthesis.
Results
Trypanosoma cruzi NST candidates
We initially searched for putative nucleotide sugar trans-
porters in the T. cruzi genome by performing Blastp
searches in GeneDB [16] using characterized NSTs of
different organisms as queries. We have identified a family
of eleven putative NSTs (Table 1) showing considerable
similarity (e-value < 1e-10) to known NSTs. Consistent
with their putative assigned function, the genes code for
multi-transmembrane (TM) proteins displaying between 7
and 10 TM domains (Table 1).
Due to the hybrid nature of the diploid CL Brener
strain [17], both haplotypes of nine of the genes could be
identified based on similarity and synteny (alleles are indi-
cated in parentheses in Table 1). The alleles in each pair
are at least 90 % identical to each other at the amino acid
level and, with two exceptions, code for proteins of identi-
cal or similar size (up to three amino acids in difference).
The genes TcCLB.509127.90 and TcCLB.511817.280, how-
ever, have an extended amino terminus when compared to
their respective alleles. Comparison of the predicted pro-
tein products with the corresponding homologues in T.
cruzi Sylvio ×10/1, a non-hybrid strain whose draft genome
sequence was made available more recently [18], and also
with the putative homologues in T. brucei and Leishmania
spp., suggests that for both genes the amino terminal
extension results from annotation errors (data not shown).
Table 1 Putative NSTs identified in the T. cruzi genome (Clone CL Brener)
Genea Number of amino acids Identity in amino acids
between alleles (%)
TM domainsb
TcCLB.511517.150 (TcCLB.511737.70) (TcNST1) 313 (313) 99 9
TcCLB.511301.50 (TcCLB.511353.30) 316 (316) 98 8
TcCLB.510355.220 (TcCLB.506753.60) 322 (322) 97 9
TcCLB.506509.40 (TcCLB.506579.80) 347 (344) 95 9
TcCLB.509741.20 (TcCLB.507625.200) 355 (355) 96 10
TcCLB.506793.40 (TcCLB.510611.20) 387 (390) 90 10
TcCLB.504085.60 (TcCLB.507089.40) 412 (412) 93 8
TcCLB.508737.180 (TcCLB.509127.90) 444 (494) 96 9
TcCLB.511817.280 (TcCLB.510531.10) 541 (484) 98 9
TcCLB.511277.400 350 – 7
TcCLB.504057.120 358 – 9
aEleven putative T. cruzi NSTs were identified in GeneDB by perfoming Blastp searches using characterized NSTs of different organisms as queries. For nine of the
genes both haplotypes could be identified based on similarity and synteny. The hybrid diploid CL Brener strain is composed of haplotypes named Esmeraldo-like
and non-Esmeraldo-like. Genes (and their respective number of amino acids) derived from Esmeraldo-like haplotypes are indicated in parentheses
bNumber of transmembrane domains (for non-Esmeraldo like genes only) were predicted using the TMHMM Server 2.0 (http://www.cbs.dtu.dk/services/TMHMM/)
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T. cruzi UDP-GlcNAc transporter
It is not possible to determine the substrate specificity of
a given NST by analysis of its amino acid sequence [8].
To identify UDP-GlcNAc transporters, we used a yeast
complementation approach in which a Kluyveromyces
lactis mutant deficient in the Golgi transport of UDP-
GlcNAc was used [19]. This mutant has been used for
the identification of UDP-GlcNAc transporters from
canine cells [20], Caenorhabditis elegans [21] and T. bru-
cei [13]. Complementation assays are based on the less
intense binding of the GS-II lectin from Griffonia simpli-
cifolia, which specifically recognizes terminal GlcNAc
residues, to the mutant cell surface.
Although sequence similarity is not particularly useful for
substrate specificity prediction, we used the UDP-GlcNAc
transporters from T. brucei [13], a closely related parasite,
to restrict our candidate genes. Based on phylogenetic
analysis between the putative T. cruzi transporters and
known NSTs from different organisms (Fig. 1), the genes
TcCLB.511277.400, TcCLB.504085.60, TcCLB.504057.120
and TcCLB.511517.150 code for the closest transporters
to TbNST1, 2, 3 and 4, respectively. These genes, indi-
cated by arrows in Fig. 1, were then used for the comple-
mentation assays in K. lactis.
Only the transporter encoded by the TcCLB.511517.150
gene, TcNST1, could rescue the wild-type phenotype
(Fig. 2a). Restoration of GSII lectin binding to levels simi-
lar to those of wild-type cells was observed in approxi-
mately 50 % of cells transfected with TcNST1. Similar
results have been observed for the heterologous expression
of NSTs in yeast, and it is likely related to the expression
of nonfunctional transporters [ 22]. The mean fluores-
cence intensity values are presented in Fig. 2b. For cells ex-
pressing TcNST1, the fluorescence intensity corresponded
to approximately 60 % of wild-type levels, a finding that is
in agreement with half of the cells not restoring GS-II
lectin binding. As a positive control, we used the K. lactis
UDP-GlcNAc transporter (Kl UGT), whose activity is defi-
cient in the yeast mutant strain. The expression of the
other genes in the K. lactis mutant cells did not increase
binding of the lectin (Additional file 1). Expression of these
genes in K. lactis was analyzed by western blotting using a
monoclonal antibody against the histidine tail inserted at
the carboxyl-terminal of the transporters. However, our re-
sults regarding level of expression and apparent molecular
weight were not conclusive (data not shown). Therefore,
the incapacity of TcCLB60, TcCLB120 and TcCLB400 to
complement the K. lactis mutant could be due to lack of
proper expression in the yeast cells.
The TcCLB.511517.150 gene and its allele TcCLB.511737.70
are both composed of 942 nucleotides and code for
a 313-amino acid polypeptide. There is only one amino
acid difference between them, in which an asparagine resi-
due is replaced by a serine (N74S) in TcCLB.511517.150.
Sequencing of the gene from T. cruzi clone Dm28c, which
was used in this work, revealed a protein identical to its
homologue in T. cruzi Sylvio ×10/1, encoded by the gene
TCSYLVIO_003299. This protein differ by three amino
acids to that encoded by the gene TcCLB.511517.150
in T. cruzi CL Brener (K7N, L168V, and L234F in
TcCLB.511517.150).
Many NSTs are multisubstrate transporters, including
the recently characterized T. brucei transporters. TbNST4
is the closest T. brucei transporter to TcNST1, and it can
transport UDP-GlcNAc, UDP-GalNAc and GDP-Man.
Next, we decided to test whether TcNST1 would also
be able to transport GDP-Man because mannose resi-
dues are important for T. cruzi glycoconjugates (Gal-
NAc residues are not present in either T. cruzi or T. brucei
glycoconjugates). The capacity to transport GDP-Man was
assessed by complementation of a Saccharomyces cerevisiae
mutant partially deficient in GDP-Man transport (NDY5
strain) [23] using a fusion protein TcNST1-V5. As shown
in Fig. 3a, TcNST1 could not restore growth of the yeast
cells in the presence of the anionic dye Congo red. To rule
out the possibility that TcNST1 was not expressed in the
yeast cells, western blot analyses were carried out using an
anti-V5 monoclonal antibody. TcNST1 is visualized in total
protein extracts of cells transfected with the vector encod-
ing TcNST1-V5 but not in cells transfected with the empty
vector (Fig. 3b).
TcNST1 subcellular localization and gene expression
That TcNST1 could restore UDP-GlcNAc transport in the
K. lactis mutant suggested the Golgi apparatus as its prob-
able subcellular localization. To investigate this hypothesis
in T. cruzi, we used a chimeric protein in which green
fluorescent protein (GFP) was fused to the N-terminus
of TcNST1. After transfection and selection of neomycin-
resistant cells, T. cruzi epimastigotes were analyzed by
fluorescence microscope. Transfected epimastigotes with
the GFP-TcNST1 fusion protein displayed a dot signal at
the anterior region of the parasite while fluorescence emit-
ted by transfectants expressing only GFP-Flag (GFP fused
at the C-terminus with Flag) was distributed through the
cytoplasm. Wild-type cells had little intrinsic fluorescence
(Additional file 2). Next we used a monoclonal antibody
against GFP to detect expression of GFP-TcNST1 in total
extracts of epimastigotes. As shown in Additional file 3, the
transporter fused to GFP is present in transfected epimasti-
gotes but not in wild-type cells. The Golgi localization
of TcNST1 was confirmed by co-localization with TcHIP, a
putative T. cruzi zDHHC palmitoyl transferase recently
shown to be localized to the Golgi apparatus [24]. A clear
punctual signal in close contact with the kinetoplast, as
would be expected for a Golgi resident protein (Fig. 4b, d),
was shown to co-localize with TcHIP (Fig. 4c, d).
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TcNST1 expression was analyzed by semi-quantitative
RT-PCR along the life cycle of T. cruzi and during the
process of metacyclogenesis in vitro, in which epimasti-
gotes in the late exponential phase are differentiated into
metacyclics under nutritional stress in a chemically de-
fined differentiation medium [25]. In this medium, called
TAU3AAG, epimastigotes adhere to a substrate and are
released as metacyclics after approximately 100 h.
Fig. 1 Phylogenetic analysis of NSTs from different organisms and the putative T. cruzi NSTs. Experimental characterized substrates are indicated
in parentheses. T. cruzi NSTs used for complementation assays in K. lactis are indicated by arrows. Sequences were aligned using ClustalX2.1 and
the tree was constructed with Mega5.2. Statistical method: Neighbor-Joining. Model: p-distance. Number of bootstraps replications: 1000. AtUDP-GalT1,
A. thaliana UDP-GalT1 (21281057); CeGDP-Fuc, C. elegans GDP-Fuc (20138279); CeC03H5.2, C. elegans C03H5.2 (24636210); CnGMT1, C. neoformans GMT1
(68137387); DmGFR, D. melanogaster GFR (7299013); HsSLC35C1, Homo sapiens SLC35C1 (13940506); HsSLC35A2-hUGT2, H. sapiens SLC35A2-hUGT2
(1669566); HsSLC35A1, H. sapiens SLC35A1 (5453621); KlUDP-GlcNAc, K. lactis UDP-GlcNAc (1373152); LmPG2, L. major LPG2 (157876110); LmLPG5A, L. major
LPG5A (45649089); LmLPG5B, L. major LPG5B (45649091); ScVRG4, S. cerevisiae VRG4 (6321213); TbNST1, T. brucei NST1 (Tb927.10.13900); TbNST2, T. brucei
NST2 (Tb927.11.16560); TbNST3, T. brucei NST3 (Tb927.4.1640); TbNST4, T. brucei NST4 (Tb927.6.3960). GI numbers are indicated in parentheses
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According to the results shown in Fig. 5, TcNST1 mRNA
is present in all four major life forms of T. cruzi and in
intermediate forms during differentiation from epimasti-
gotes to metacyclics. While post-transcriptional control of
gene expression is particularly important in trypanosoma-
tids, the presence of mRNA suggests that the transporter
may be expressed in all life forms of the parasite.
Discussion
We have identified a family of eleven putative NSTs from
T. cruzi (Table 1). These putative transporters show an
overall structural similarity with other members of the
NST family. Syntenic homologues to the TcCLB.511301.50
and TcCLB.506509.40 genes are present in Leishmania
spp. (L. donovani, L. infantum, L. major, L. mexicana) but
not in T. brucei. For all the other putative T. cruzi NSTs,
there is a clear syntenic homologue in T. brucei. As has
been noted by Capul et al. [12], an interesting role for
transporters shared by Leishmania spp and T. cruzi in-
volves UDP-galactofuranose (UDP-Galf), which is present
in both trypanosomatids but not in T. brucei. According to
our phylogenetic analyses and the TriTrypDB, two T. cruzi
NSTs, TcCLB.510355.220 and TcCLB.506793.40, have no
clear homologues in T. brucei or Leishmania. Similarly, pu-
tative roles for these transporters could be the transport of
UDP-xylose (UDP-Xyl) and UDP-rhamnopyranose (UDP-
Rha), which are synthesized only by T. cruzi [26].
Eight nucleotide sugars have been identified in T. cruzi
by spectrometry [26], GDP-Man, UDP-GlcNAc, UDP-
glucose (UDP-Glc), UDP-Gal, UDP-Galf, UDP-Xyl, UDP-
Rha and GDP-fucose. Accordingly, the corresponding
sugars have been identified in T. cruzi glycoconjugates [27].
Because we have identified eleven putative NSTs, and as-
suming that they are all functional, redundancy likely exists
between these transporters, as has been reported in other
organisms. In fact, the four recently characterized T. brucei
NSTs can transport UDP-GlcNAc, two of them (TbNST1-
2) transport UDP-Gal, and the other two (TbNST3-4)
transport GDP-Man.
TcNST1 showed the greatest values of similarity (using
Blastp and considering Query Coverage > 90 %) to the T.
brucei TbNST4 transporter (79 %), the Arabidopsis
thaliana UDP-Gal transporter UDP-GalT1 (51 %) and
the Aspergillus fumigatus UDP-galactofuranose trans-
porter GlfB (44 %). The K. lactis UDP-GlcNAc trans-
porter, whose deficient activity in the yeast mutant strain
Fig. 2 Identification of a UDP-GlcNAc transporter (TcNST1) of T. cruzi by in vivo complementation assays. K. lactis mutant (Kl3) cells were transfected with
TcNST1, the K. lactis UDP-GlcNAc transporter (Kl UGT, positive control) or empty vector (pE4, negative control). Wild-type K. lactis cells were included in the
analysis for comparison. Cells were grown as described in the Methods section. After labeling with GS-II lectin (Alexa Fluor 488 conjugate), yeast cells were
separated by flow cytometry in a FACS Canto II (Becton & Dickinson). a Representative histograms showing lectin binding transfected cells.
b Mean fluorescence intensities of a representative experiment in triplicate. Error bars represent the standard deviations. * p < 0.01
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Fig. 4 TcNST1 is localized to the Golgi apparatus. T. cruzi epimastigotes were transfected with a fusion construct in which TcNST1 was tagged at
the amino terminus with GFP (GFP-TcNST1). Tagged TcNST1 was localized by fluorescence microscopy after staining with anti-GFP (4b, green) and
anti-TcHIP, a Golgi marker (4c, red). Kinetoplasts (large arrow) and nuclei (arrowhead) were stained with DAPI (4d, blue). Secondary antibody controls
showed no fluorescence signal (data not shown)
Fig. 3 TcNST1 cannot complement a S. cerevisiae mutant strain deficient in GDP-Man transport. a S. cerevisiae strain NDY5 was transfected with
TcNST1-V5, the S. cerevisiae GDP-Man Vrg4p transporter (positive control) or empty vector (pYEST-DEST 52, negative control). Wild-type S. cerevisiae
(JPY25 6c) cells were included in the analysis for comparison. Transfected cells were grown to exponential phase in liquid cultures of SCM-URA,
adjusted to an OD of approximately one (lanes 1 and 2) and submitted to ten-fold serial dilution (lanes 3–5). Cells were then inoculated on solid
agar plates containing YP plus 2 % galactose and 1.6 μg/ml Congo red. Growth was assessed after 4 days at 30 °C. b Western blot analysis of
strain NDY5 transfected with empty vector (lane 1) or TcNST1-V5 (lane 2). TcNST1 expression was detected with a mouse anti-V5 antibody. Expression
of histone 3 was used as an internal control
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was compensated by TcNST1, is a more distantly related
transporter (Fig. 1), constituting another example of the
difficulty involved in determining the substrate specifi-
city of NSTs based on primary sequence analysis.
We also tested the capacity of TcNST1 to transport
GDP-Man in yeast cells. The complementation test was
negative (Fig. 3). TcNST1 was shown to be expressed in
the yeast cells by western blotting, but we cannot rule
out that the transporter is not functional in S. cerevisiae
by mislocalization. Therefore, even though our results
suggest that GDP-Man is not a substrate for TcNST1 in
the parasite it is not a definite conclusion. A conserved
GALNK motif associated with binding to GDP-Man was
identified in the S. cerevisiae VRG4 GDP-Man transporter
[28]. The same motif is present in the GDP-Man trans-
porters of Cryptococcus neoformans (GMT1), T. brucei
(TbNST3) and L. major (LPG2). Interestingly, in TbNST4,
which transports GDP-Man, and TcNST1, this motif is
less conserved, but a leucine residue, which is important
for VRG4 function at physiological levels [28], is present
in TbNST4 (Leu267) but not TcNST1.
NSTs are mainly localized to the Golgi apparatus. How-
ever, in trypanosomatids, nucleotide sugars are supposed
to be synthesized in glycosomes [29, 30]. It was important,
then, to investigate the subcellular localization of TcNST1.
Our results (Fig. 4) suggest a clear Golgi localization
with no indication of the presence of the transporter
in glycosomes.
UDP-GlcNAc is an important substrate for the three try-
panosomatids discussed here because it is required for the
synthesis of both the conserved core of GPI anchors and
the oligosaccharide core of N-glycans [27]. In T. brucei, in
which the synthesis of UDP-GlcNAc is essential for para-
site survival, the pool of UDP-GlcNAc inside the Golgi
lumen is necessary for the synthesis of N-acetyllactosa-
mine [31]. In T. cruzi, the Golgi content of UDP-GlcNAc
is important for the synthesis of O-linked glycans in mu-
cins, which starts with the attachment of GlcNAc, from
UDP-GlcNAc, to a Ser or Thr residue via an α-N-acetyl-
glucosaminyltransferase [32–34]. Therefore, the transport
of UDP-GlcNAc across the Golgi membrane is essential
for the proper synthesis of T. cruzi mucins.
Conclusions
TcNST1 is a UDP-GlcNAc transporter specifically localized
to the Golgi apparatus. Due to its specificity and subcellular
localization, it is tempting to speculate that TcNST1 may
have a role on the synthesis of T. cruzi mucins. Moreover,
the expression of TcNST1, at the mRNA level, in all life
forms of T. cruzi is in agreement with the expression of
mucins throughout the life cycle of the parasite. Loss-of-
function studies of this transporter are underway to unravel
its role in T. cruzi glycosylation.
Methods
Trypanosome cultures
Epimastigotes of Trypanosoma cruzi Dm28c clone were
maintained in liver-infusion tryptose (LIT) medium con-
taining 10 % of fetal bovine serum (FBS) at 28 °C as previ-
ously described [35]. Transfection of epimastigotes in
exponential growth phase was performed by electropor-
ation [36] and transfectants were selected in the presence
of G418 (500 μg/ ml). Metacyclics were obtained by in
vitro differentiation of epimastigotes under nutritional
stress using chemically defined axenic conditions as de-
scribed [25]. After differentiation, metacyclic trypomasti-
gotes were purified with ion exchange chromatography on
diethylaminoethyl - cellulose columns. The metacyclics
obtained after purification usually contain less than 1 %
of epimastigotes-like forms. Cell-derived amastigotes and
trypomastigotes were obtained by infection of VERO cells
with metacyclic forms. Trypomastigotes were released
in the supernatant of VERO cell cultures 4 days after
infection and harvested by centrifugation. Amastigotes
were obtained by disruption of VERO cells 2 days after in-
fection. According to optical microscopic analyses cross-
contamination between amastigotes and trypomastigotes
are typically less than 5 %.
Yeast strains and growth conditions
The Kluyveromyces lactis wild-type strain MG1/2 and
mutant strain KL3 [19] were kindly provided by Dr. C.B.
Hirschberg and Dr. C. Bendixen. The Saccharomyces
cerevisiae strain JPY25 6c and the mutant strain NDY5
were kindly provided by Dr. N. Dean. Yeast strains were
grown at 30 °C on rich medium (YPD) or on synthetic
complete medium lacking uracil (YNB supplemented
with drop-out medium without uracil, SCM-URA).
Fig. 5 TcNST1 is expressed at the mRNA level in all life forms of T. cruzi
and during metacyclogenesis in vitro. RT-PCR analysis of TcNST1 mRNA
expression in epimastigotes (Epi), cell-culture-derived trypomastigotes
(Trypo), amastigotes (Ama), metacyclics (Meta) and intermediary forms
during metacyclogenesis: epimastigotes in the late exponential phase
(LEP), epimastigotes under nutritional stress (Stress) and adhered
epimastigotes (Adh). Expression of the 60S ribosomal protein L9 was
used as an internal control (TcCLB.504181.10). Aliquots of all samples
were pooled together and subjected to reverse transcription without
reverse transcriptase (− RT)
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Plasmid construction
For the complementation assays in K. lactis, the coding
sequences of the candidate genes were first amplified by
PCR from T. cruzi genomic DNA using specific primers
and then cloned into the pE4 vector [20]. The K. lactis
UDP-GlcNAc transporter was used as a positive control.
The corresponding gene of the wild-type MG1/2 strain
was amplified from genomic DNA and cloned into the
same vector. The primers and restriction sizes used for
cloning are indicated in Additional file 4.
The plasmids used for expression in S. cerevisiae and T.
cruzi were constructed using Gateway Technology (Invi-
trogen). TcNST1 and the S. cerevisiae GDP-Man trans-
porter ScVRG4 were first cloned into the pDONR 221
vector and then transferred by recombination to the des-
tination vectors pYES-DEST 52 (Invitrogen) and pTcGFPN
[37] for expression in S. cerevisiae and T. cruzi, respect-
ively. The pYES-DEST 52 vector contains the V5 epitope
at the carboxyl-terminus for protein detection and the
pTcGFPN vector contains GFP at the amino-terminus and
neomycin as a selectable marker. GFP was cloned into the
vector pTcGW-3xFlag-Neo, a modified vector derived
from the cloning system developed by Batista et al. [37]
and kindly provided by Dr. Stenio P Fragoso. All plasmids
were confirmed by sequencing.
Complementation assays
K. lactis cells transfected with putative T. cruzi NSTs
cloned into the pE4 vector [20] were grown on selective
medium (SCM-URA). Cell-surface labeling with GS-II
lectin was performed according to [20]. Lectin binding
was analysed by flow cytometry in a FACS Canto II
(Becton & Dickinson). The sensitivity of the S. cerevisiae
strain NDY5 to Congo red was assessed by growth on
solid agar plates containing YP plus 2 % galactose and
1.6 μg/ml of the dye. Galactose was used as a carbon
source because the pYES-DEST 52 vector contains the
yeast GAL1 promoter. Transfected cells in exponential
growth were adjusted to an OD of approximately one
and then submitted to ten-fold serial dilution. Growth
was assessed after 4 days at 30 °C.
Immunofluorescence analysis
Transfected epimastigotes expressing TcNST1 in fusion
with GFP were used for subcellular localization experi-
ments. GFP intrinsic fluorescence of epimastigotes ex-
pressing GFP-TcNST1 or GFP-Flag was visualized in live
parasites. For co-localization experiments with TcHIP,
cells were incubated with rabbit anti-GFP (1:400) and
mouse anti-TcHIP (1:100) [24], after fixation (4 % for-
maldehyde), permeabilization (0.1 % Triton X-100) and
blocking (2 % BSA). Secondary antibodies conjugated to
Alexa 488 (goat anti-rabbit IgG) and Alexa 594 (goat
anti-mouse IgG) were used. Genomic and kinetoplast
DNA was visualized with 4′,6-diamidino-2-phenylindole
(DAPI). Slides were examined using a Leica DMI6000 B
inverted microscope.
Western blot analysis
Total protein extracts were prepared from exponential
growing yeast cells on SCM-URA supplemented with 2 %
galactose. Cells were disrupted by glass beads in the pres-
ence of RIPA buffer. Cell lysates from T. cruzi epimasti-
gotes (5 × 106 parasites) were obtained by direct lysis in
Laemmli buffer. After electrophoresis on SDS-PAGE gels
(13 %), proteins were electrotransferred onto Optitran
BA-S85 membranes (GE Healthcare). Membrane-bound
proteins were incubated either with mouse anti-V5 anti-
body and rabbit anti-human histone 3 or with rabbit
anti-GFP and mouse anti-GAPDH. Protein detection was
performed using alkaline phosphatase or the Li-COR
Odyssey imaging system.
Total RNA isolation and reverse transcription
Total RNA was isolated from trypanosome cells using the
RNeasy® Mini Kit (Qiagen). Any contaminant DNA was
digested with 1 U per μg of RNA with RNase-free DNase
(Promega). Aliquots of 1 μg of total RNA were then re-
verse transcribed to first-strand cDNA using oligo (dT)
primers. Amplification by PCR was performed with the
primers Tc150F4 (5′GTACTTCAAGACGGCGTTGG3′)
and Tc150R4 (5′GGCTGACAGTCCGTTCATCT3′) for
TcCLB.511517.150 and L9F (5′CCTTCACTGCCGTTCG
TTGGTTTG3′) and L9R (5′ATGCGAGAGTGCCGTG
TTGATGGT3′) for the 60S ribosomal L9 gene used as an
internal control.
Additional files
Additional file 1: T cruzi candidate genes tested for UDP-GlcNAc
transport by in vivo complementation assays. K. lactis mutant (Kl3) cells
were transfected with TcCLB.504057.120 (TcCLB120), TcCLB.504085.60
(TcCLB60) and TcCLB.511277.400 (TcCLB400), the K. lactis UDP-GlcNAc
transporter (Kl UGT, positive control) or empty vector (pE4, negative
control). Cells were grown as described in the Methods section. After
labeling with GS-II lectin (Alexa Fluor 488 conjugate), yeast cells were
separated by flow cytometry in a FACS Canto II flow cytometer (Becton
& Dickinson). (TIF 1867 kb)
Additional file 2: Intrinsic fluorescence emitted by transfected
parasites expressing GFP-TcNST1. Epimastigotes expressing the
transporter fused to GFP display a single dot at the anterior region of
the parasite. Live parasites from cultures of epimastigotes in
exponential growth were washed once with PBS, mounted onto
slides and immediately visualized in Leica DMI6000 B inverted
microscope. (TIF 1386 kb)
Additional file 3: Expression of GFP-TcNST1 in T. cruzi epimastigotes.
Western blot analysis of T. cruzi parasites transfected with GFP-TcNST1 and
wild-type cells. Expression of the fusion protein (arrow) was detected with a
monoclonal antibody against GFP. Expression of glyceraldehyde 3-phosphate
dehydrogenase (GAPDH, ~ 37 kDa) was used as an internal control. (TIF 69 kb)
Additional file 4: Primers used for cloning of the listed genes in
different expression vectors. (DOCX 15 kb)
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